Tokyo, Sept. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062850) titled 'Study on Thermophysiological Responses to Radiofrequency Electromagnetic Fields toward Beyond 5G' on Sept. 8.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Non-randomized Blinding - Single blind -participants are blinded Control - Placebo

Primary Sponsor: Institute - Kurume University School of Medicine

Condition: Condition - Healthy volunteers Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to investigate the effects of radiofrequency electromagnetic field exposure on the human body by locally exposing human skin to radiofrequency electromagnetic fields in frequency bands expected to be used for Beyond 5G and evaluating physiological responses, including skin temperature, blood flow, and thermal sensation, thereby providing scientific evidence for the development of safe communication technologies and safety standards. Basic objectives2 - Safety

Intervention: Interventions/Control_1 - Sham exposure Interventions/Control_2 - Exposure at A

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - 1. Individuals aged 18 to 79 years at the time of informed consent who are not currently enrolled in high school. 2. Individuals who provide written informed consent to participate in the study. 3. Individuals without severe diseases that interfere with daily activities. Individuals with common chronic diseases, such as hypertension, may be included if the condition is appropriately controlled under medical supervision and participation in the study is considered acceptable. 4. Individuals judged by the principal investigator to be eligible to participate based on an interview and assessment of lifestyle-related information. Key exclusion criteria - 1. Individuals who do not meet the above inclusion criteria. 2. Individuals found to have provided false information at the time of informed consent or during participation in the study. Target Size - 24

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 09 Month 07 Day Anticipated trial start date - 2026 Year 09 Month 14 Day Last follow-up date - 2029 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071950

Disclaimer: Curated by HT Syndication.